Active biotechnology investors in Washington — 2026
400 investors backed 15 biotechnology offerings by companies in Washington in the last 12 months, per SEC Form D. Companies file a Form D with the SEC when they raise money under Regulation D, and report how many investors have already put money in. Funds file one too when they raise, which is how we list the venture and private equity funds based in Washington. Figures come straight from SEC EDGAR and refresh daily.
- Investors in these offerings
- 400
- Form D “total number already invested” · All 15 offerings, Sep 28, 2025 – Sep 28, 2026
- New biotechnology offerings
- 15
- Companies in Washington that filed a new Form D, Sep 28, 2025 – Sep 28, 2026
- Amount sold
- $101.0M
- As reported in Form D · All 15 offerings, Sep 28, 2025 – Sep 28, 2026
Offerings are matched on the Form D industry group (Biotechnology) and the company’s business address, one offering per company, funds excluded. Each filing reports how many investors have already invested, not who they are, so an investor in two offerings counts twice. Run the same search on sec.gov.
Venture and private equity funds based in Washington
SEC EDGAR Form D filingsFunds file a Form D when they raise from their own investors. These are recent filings by venture capital and private equity funds with a business address in Washington, from the last 7 days, newest first.
Funds with “Bio”, “Biotech”, “Biotechnology”, “Bioscience” in their name
Form D doesn’t say what a fund invests in, so this is a keyword match on the fund’s name, not a stated biotechnology focus. Venture capital and private equity funds in Washington that filed in the last 12 months.
Organisation-level public data from SEC EDGAR. We don’t publish personal names or contact details on this page. Fund size is the offering amount in the fund’s Form D; “Indefinite” means the filing didn’t state one.
In OmniLead
From fund filings to the people who run the funds.
The Investors lens lists funds from their Form D filings with fund type, fund size and last filing date, plus the executive officers and managing members each filing names. Contacts come from the fund’s own website, with the source on every row.
Biotechnology in other states
Raising in Washington? Find investors who fit.
Search investors built from SEC Form D filings, see why each one matches your round, and reach them from your own inbox.